Corient Private Wealth
AVNS

Corient Private Wealth’s Avanos Medical AVNS Stock Holding History

Corient Private Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,219
Closed -$171K – 3059
2026
Q1 		$171K Sell
12,219
-8,636
-41% -$116K ﹤0.01% 2596
2025
Q4 		$234K Buy
+20,855
New +$239K ﹤0.01% 2337

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Corient Private Wealth's AVNS Position: Q2 2026 in Review

Corient Private Wealth sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 12,219 shares — an estimated $171K sold.

Corient Private Wealth first reported a position in AVNS in Q4 2025 and held it in 2 quarters. The position peaked at $234K in Q4 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Corient Private Wealth reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Corient Private Wealth sold 12,219 Avanos Medical shares in Q2 2026, an estimated $171K.
  • Corient Private Wealth first reported a position in Avanos Medical in Q4 2025 and held it in 2 quarters.
  • Corient Private Wealth's Avanos Medical position peaked at $234K in Q4 2025.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.